nodes	percent_of_prediction	percent_of_DWPC	metapath
Diltiazem—ABCB1—Mitomycin—urinary bladder cancer	0.124	0.237	CbGbCtD
Diltiazem—CYP3A4—Thiotepa—urinary bladder cancer	0.0563	0.108	CbGbCtD
Diltiazem—CYP2C8—Fluorouracil—urinary bladder cancer	0.0451	0.0861	CbGbCtD
Diltiazem—CYP3A5—Etoposide—urinary bladder cancer	0.0392	0.0748	CbGbCtD
Diltiazem—CYP2C8—Etoposide—urinary bladder cancer	0.0377	0.0719	CbGbCtD
Diltiazem—ABCB1—Gemcitabine—urinary bladder cancer	0.0357	0.0682	CbGbCtD
Diltiazem—CYP2C9—Fluorouracil—urinary bladder cancer	0.0315	0.0601	CbGbCtD
Diltiazem—CYP2C9—Cisplatin—urinary bladder cancer	0.0267	0.051	CbGbCtD
Diltiazem—ABCB1—Cisplatin—urinary bladder cancer	0.0259	0.0495	CbGbCtD
Diltiazem—ABCB1—Etoposide—urinary bladder cancer	0.0255	0.0487	CbGbCtD
Diltiazem—ABCB1—Doxorubicin—urinary bladder cancer	0.0174	0.0332	CbGbCtD
Diltiazem—ABCB1—Methotrexate—urinary bladder cancer	0.0168	0.0321	CbGbCtD
Diltiazem—CYP2D6—Doxorubicin—urinary bladder cancer	0.0164	0.0313	CbGbCtD
Diltiazem—CYP3A4—Etoposide—urinary bladder cancer	0.0153	0.0292	CbGbCtD
Diltiazem—CYP3A4—Doxorubicin—urinary bladder cancer	0.0104	0.0199	CbGbCtD
Diltiazem—CACNA1S—seminal vesicle—urinary bladder cancer	0.00469	0.118	CbGeAlD
Diltiazem—CYP2C19—urine—urinary bladder cancer	0.00468	0.118	CbGeAlD
Diltiazem—CYP2C9—urine—urinary bladder cancer	0.00363	0.0911	CbGeAlD
Diltiazem—CYP3A4—urine—urinary bladder cancer	0.00277	0.0695	CbGeAlD
Diltiazem—CYP2D6—urine—urinary bladder cancer	0.00272	0.0684	CbGeAlD
Diltiazem—CACNA1C—prostate gland—urinary bladder cancer	0.00269	0.0676	CbGeAlD
Diltiazem—CACNA1C—smooth muscle tissue—urinary bladder cancer	0.0019	0.0478	CbGeAlD
Diltiazem—CACNA1C—female reproductive system—urinary bladder cancer	0.00147	0.0369	CbGeAlD
Diltiazem—CACNA1C—vagina—urinary bladder cancer	0.00133	0.0334	CbGeAlD
Diltiazem—CYP3A5—prostate gland—urinary bladder cancer	0.00132	0.0332	CbGeAlD
Diltiazem—CYP2C8—renal system—urinary bladder cancer	0.000999	0.0251	CbGeAlD
Diltiazem—CYP3A5—renal system—urinary bladder cancer	0.000902	0.0227	CbGeAlD
Diltiazem—CACNA1C—lymph node—urinary bladder cancer	0.000858	0.0216	CbGeAlD
Diltiazem—CYP2C19—vagina—urinary bladder cancer	0.000829	0.0208	CbGeAlD
Diltiazem—CYP2C8—female reproductive system—urinary bladder cancer	0.0008	0.0201	CbGeAlD
Diltiazem—CYP2C8—vagina—urinary bladder cancer	0.000724	0.0182	CbGeAlD
Diltiazem—CYP2C9—female reproductive system—urinary bladder cancer	0.000711	0.0179	CbGeAlD
Diltiazem—ABCB1—prostate gland—urinary bladder cancer	0.000703	0.0177	CbGeAlD
Diltiazem—CYP3A4—renal system—urinary bladder cancer	0.000677	0.017	CbGeAlD
Diltiazem—CYP2D6—renal system—urinary bladder cancer	0.000666	0.0167	CbGeAlD
Diltiazem—CYP3A5—vagina—urinary bladder cancer	0.000653	0.0164	CbGeAlD
Diltiazem—ABCB1—seminal vesicle—urinary bladder cancer	0.000594	0.0149	CbGeAlD
Diltiazem—CYP3A4—female reproductive system—urinary bladder cancer	0.000542	0.0136	CbGeAlD
Diltiazem—CYP2D6—female reproductive system—urinary bladder cancer	0.000533	0.0134	CbGeAlD
Diltiazem—ABCB1—epithelium—urinary bladder cancer	0.000516	0.013	CbGeAlD
Diltiazem—ABCB1—renal system—urinary bladder cancer	0.000479	0.012	CbGeAlD
Diltiazem—ABCB1—urethra—urinary bladder cancer	0.00047	0.0118	CbGeAlD
Diltiazem—ABCB1—female reproductive system—urinary bladder cancer	0.000384	0.00964	CbGeAlD
Diltiazem—ABCB1—vagina—urinary bladder cancer	0.000347	0.00872	CbGeAlD
Diltiazem—Pharyngitis—Methotrexate—urinary bladder cancer	0.000227	0.000714	CcSEcCtD
Diltiazem—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.000226	0.00071	CcSEcCtD
Diltiazem—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000226	0.00071	CcSEcCtD
Diltiazem—Weight increased—Doxorubicin—urinary bladder cancer	0.000225	0.000708	CcSEcCtD
Diltiazem—Epistaxis—Epirubicin—urinary bladder cancer	0.000225	0.000707	CcSEcCtD
Diltiazem—Pruritus—Gemcitabine—urinary bladder cancer	0.000225	0.000707	CcSEcCtD
Diltiazem—ABCB1—lymph node—urinary bladder cancer	0.000224	0.00564	CbGeAlD
Diltiazem—Nausea—Thiotepa—urinary bladder cancer	0.000224	0.000705	CcSEcCtD
Diltiazem—Urethral disorder—Methotrexate—urinary bladder cancer	0.000224	0.000705	CcSEcCtD
Diltiazem—Sinusitis—Epirubicin—urinary bladder cancer	0.000224	0.000703	CcSEcCtD
Diltiazem—Feeling abnormal—Etoposide—urinary bladder cancer	0.000223	0.000703	CcSEcCtD
Diltiazem—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.000223	0.000702	CcSEcCtD
Diltiazem—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000222	0.000699	CcSEcCtD
Diltiazem—Pruritus—Fluorouracil—urinary bladder cancer	0.000221	0.000695	CcSEcCtD
Diltiazem—Visual impairment—Methotrexate—urinary bladder cancer	0.00022	0.000693	CcSEcCtD
Diltiazem—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000219	0.000688	CcSEcCtD
Diltiazem—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000218	0.000686	CcSEcCtD
Diltiazem—Bradycardia—Epirubicin—urinary bladder cancer	0.000218	0.000685	CcSEcCtD
Diltiazem—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000217	0.000683	CcSEcCtD
Diltiazem—Renal failure—Doxorubicin—urinary bladder cancer	0.000217	0.000682	CcSEcCtD
Diltiazem—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000216	0.00068	CcSEcCtD
Diltiazem—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000216	0.00068	CcSEcCtD
Diltiazem—Urticaria—Etoposide—urinary bladder cancer	0.000215	0.000677	CcSEcCtD
Diltiazem—Rhinitis—Epirubicin—urinary bladder cancer	0.000214	0.000675	CcSEcCtD
Diltiazem—Body temperature increased—Etoposide—urinary bladder cancer	0.000214	0.000674	CcSEcCtD
Diltiazem—Abdominal pain—Etoposide—urinary bladder cancer	0.000214	0.000674	CcSEcCtD
Diltiazem—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000214	0.000674	CcSEcCtD
Diltiazem—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000214	0.000674	CcSEcCtD
Diltiazem—Hepatitis—Epirubicin—urinary bladder cancer	0.000214	0.000673	CcSEcCtD
Diltiazem—Eye disorder—Methotrexate—urinary bladder cancer	0.000214	0.000672	CcSEcCtD
Diltiazem—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000214	0.000672	CcSEcCtD
Diltiazem—Tinnitus—Methotrexate—urinary bladder cancer	0.000213	0.00067	CcSEcCtD
Diltiazem—Asthenia—Cisplatin—urinary bladder cancer	0.000212	0.000668	CcSEcCtD
Diltiazem—Pharyngitis—Epirubicin—urinary bladder cancer	0.000212	0.000668	CcSEcCtD
Diltiazem—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000212	0.000667	CcSEcCtD
Diltiazem—Sweating—Doxorubicin—urinary bladder cancer	0.000211	0.000665	CcSEcCtD
Diltiazem—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000211	0.000664	CcSEcCtD
Diltiazem—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000211	0.000663	CcSEcCtD
Diltiazem—Urethral disorder—Epirubicin—urinary bladder cancer	0.00021	0.00066	CcSEcCtD
Diltiazem—Epistaxis—Doxorubicin—urinary bladder cancer	0.000208	0.000654	CcSEcCtD
Diltiazem—Angiopathy—Methotrexate—urinary bladder cancer	0.000207	0.000652	CcSEcCtD
Diltiazem—Sinusitis—Doxorubicin—urinary bladder cancer	0.000207	0.000651	CcSEcCtD
Diltiazem—Dizziness—Fluorouracil—urinary bladder cancer	0.000206	0.000649	CcSEcCtD
Diltiazem—Visual impairment—Epirubicin—urinary bladder cancer	0.000206	0.000648	CcSEcCtD
Diltiazem—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000206	0.000648	CcSEcCtD
Diltiazem—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000206	0.000647	CcSEcCtD
Diltiazem—Diarrhoea—Cisplatin—urinary bladder cancer	0.000202	0.000637	CcSEcCtD
Diltiazem—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000202	0.000636	CcSEcCtD
Diltiazem—Alopecia—Methotrexate—urinary bladder cancer	0.000202	0.000635	CcSEcCtD
Diltiazem—Vomiting—Gemcitabine—urinary bladder cancer	0.000202	0.000635	CcSEcCtD
Diltiazem—Bradycardia—Doxorubicin—urinary bladder cancer	0.000201	0.000634	CcSEcCtD
Diltiazem—Rash—Gemcitabine—urinary bladder cancer	0.0002	0.00063	CcSEcCtD
Diltiazem—Dermatitis—Gemcitabine—urinary bladder cancer	0.0002	0.000629	CcSEcCtD
Diltiazem—Eye disorder—Epirubicin—urinary bladder cancer	0.0002	0.000629	CcSEcCtD
Diltiazem—Hypersensitivity—Etoposide—urinary bladder cancer	0.0002	0.000628	CcSEcCtD
Diltiazem—Tinnitus—Epirubicin—urinary bladder cancer	0.000199	0.000627	CcSEcCtD
Diltiazem—Erythema—Methotrexate—urinary bladder cancer	0.000199	0.000626	CcSEcCtD
Diltiazem—Malnutrition—Methotrexate—urinary bladder cancer	0.000199	0.000626	CcSEcCtD
Diltiazem—Headache—Gemcitabine—urinary bladder cancer	0.000199	0.000626	CcSEcCtD
Diltiazem—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000198	0.000624	CcSEcCtD
Diltiazem—Flushing—Epirubicin—urinary bladder cancer	0.000198	0.000624	CcSEcCtD
Diltiazem—Vomiting—Fluorouracil—urinary bladder cancer	0.000198	0.000624	CcSEcCtD
Diltiazem—Rhinitis—Doxorubicin—urinary bladder cancer	0.000198	0.000624	CcSEcCtD
Diltiazem—Hepatitis—Doxorubicin—urinary bladder cancer	0.000198	0.000623	CcSEcCtD
Diltiazem—Rash—Fluorouracil—urinary bladder cancer	0.000197	0.000619	CcSEcCtD
Diltiazem—Dermatitis—Fluorouracil—urinary bladder cancer	0.000197	0.000619	CcSEcCtD
Diltiazem—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000196	0.000618	CcSEcCtD
Diltiazem—Headache—Fluorouracil—urinary bladder cancer	0.000196	0.000615	CcSEcCtD
Diltiazem—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000195	0.000615	CcSEcCtD
Diltiazem—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000195	0.000613	CcSEcCtD
Diltiazem—Dysgeusia—Methotrexate—urinary bladder cancer	0.000195	0.000613	CcSEcCtD
Diltiazem—Asthenia—Etoposide—urinary bladder cancer	0.000194	0.000612	CcSEcCtD
Diltiazem—Angiopathy—Epirubicin—urinary bladder cancer	0.000194	0.00061	CcSEcCtD
Diltiazem—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000194	0.00061	CcSEcCtD
Diltiazem—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000193	0.000606	CcSEcCtD
Diltiazem—Pruritus—Etoposide—urinary bladder cancer	0.000192	0.000603	CcSEcCtD
Diltiazem—Arrhythmia—Epirubicin—urinary bladder cancer	0.000191	0.000601	CcSEcCtD
Diltiazem—Visual impairment—Doxorubicin—urinary bladder cancer	0.000191	0.0006	CcSEcCtD
Diltiazem—Alopecia—Epirubicin—urinary bladder cancer	0.000189	0.000595	CcSEcCtD
Diltiazem—Nausea—Gemcitabine—urinary bladder cancer	0.000189	0.000593	CcSEcCtD
Diltiazem—Vomiting—Cisplatin—urinary bladder cancer	0.000188	0.000592	CcSEcCtD
Diltiazem—Vision blurred—Methotrexate—urinary bladder cancer	0.000187	0.00059	CcSEcCtD
Diltiazem—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000187	0.000589	CcSEcCtD
Diltiazem—Rash—Cisplatin—urinary bladder cancer	0.000187	0.000587	CcSEcCtD
Diltiazem—Dermatitis—Cisplatin—urinary bladder cancer	0.000186	0.000586	CcSEcCtD
Diltiazem—Malnutrition—Epirubicin—urinary bladder cancer	0.000186	0.000586	CcSEcCtD
Diltiazem—Erythema—Epirubicin—urinary bladder cancer	0.000186	0.000586	CcSEcCtD
Diltiazem—Diarrhoea—Etoposide—urinary bladder cancer	0.000185	0.000583	CcSEcCtD
Diltiazem—Nausea—Fluorouracil—urinary bladder cancer	0.000185	0.000583	CcSEcCtD
Diltiazem—Eye disorder—Doxorubicin—urinary bladder cancer	0.000185	0.000582	CcSEcCtD
Diltiazem—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000185	0.000581	CcSEcCtD
Diltiazem—Tinnitus—Doxorubicin—urinary bladder cancer	0.000185	0.00058	CcSEcCtD
Diltiazem—Flushing—Doxorubicin—urinary bladder cancer	0.000184	0.000578	CcSEcCtD
Diltiazem—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000184	0.000578	CcSEcCtD
Diltiazem—Flatulence—Epirubicin—urinary bladder cancer	0.000183	0.000577	CcSEcCtD
Diltiazem—Tension—Epirubicin—urinary bladder cancer	0.000183	0.000575	CcSEcCtD
Diltiazem—Dysgeusia—Epirubicin—urinary bladder cancer	0.000182	0.000574	CcSEcCtD
Diltiazem—Nervousness—Epirubicin—urinary bladder cancer	0.000181	0.000569	CcSEcCtD
Diltiazem—Angiopathy—Doxorubicin—urinary bladder cancer	0.00018	0.000565	CcSEcCtD
Diltiazem—Malaise—Methotrexate—urinary bladder cancer	0.000179	0.000564	CcSEcCtD
Diltiazem—Dizziness—Etoposide—urinary bladder cancer	0.000179	0.000564	CcSEcCtD
Diltiazem—Muscle spasms—Epirubicin—urinary bladder cancer	0.000179	0.000563	CcSEcCtD
Diltiazem—Vertigo—Methotrexate—urinary bladder cancer	0.000179	0.000562	CcSEcCtD
Diltiazem—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000178	0.000561	CcSEcCtD
Diltiazem—Leukopenia—Methotrexate—urinary bladder cancer	0.000178	0.00056	CcSEcCtD
Diltiazem—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000177	0.000556	CcSEcCtD
Diltiazem—Nausea—Cisplatin—urinary bladder cancer	0.000176	0.000553	CcSEcCtD
Diltiazem—Vision blurred—Epirubicin—urinary bladder cancer	0.000175	0.000552	CcSEcCtD
Diltiazem—Alopecia—Doxorubicin—urinary bladder cancer	0.000175	0.00055	CcSEcCtD
Diltiazem—Cough—Methotrexate—urinary bladder cancer	0.000174	0.000546	CcSEcCtD
Diltiazem—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000173	0.000543	CcSEcCtD
Diltiazem—Vomiting—Etoposide—urinary bladder cancer	0.000172	0.000542	CcSEcCtD
Diltiazem—Malnutrition—Doxorubicin—urinary bladder cancer	0.000172	0.000542	CcSEcCtD
Diltiazem—Erythema—Doxorubicin—urinary bladder cancer	0.000172	0.000542	CcSEcCtD
Diltiazem—Rash—Etoposide—urinary bladder cancer	0.000171	0.000538	CcSEcCtD
Diltiazem—Dermatitis—Etoposide—urinary bladder cancer	0.000171	0.000537	CcSEcCtD
Diltiazem—Headache—Etoposide—urinary bladder cancer	0.00017	0.000534	CcSEcCtD
Diltiazem—Flatulence—Doxorubicin—urinary bladder cancer	0.00017	0.000534	CcSEcCtD
Diltiazem—Arthralgia—Methotrexate—urinary bladder cancer	0.000169	0.000533	CcSEcCtD
Diltiazem—Chest pain—Methotrexate—urinary bladder cancer	0.000169	0.000533	CcSEcCtD
Diltiazem—Myalgia—Methotrexate—urinary bladder cancer	0.000169	0.000533	CcSEcCtD
Diltiazem—Tension—Doxorubicin—urinary bladder cancer	0.000169	0.000532	CcSEcCtD
Diltiazem—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000169	0.000531	CcSEcCtD
Diltiazem—Malaise—Epirubicin—urinary bladder cancer	0.000168	0.000528	CcSEcCtD
Diltiazem—Discomfort—Methotrexate—urinary bladder cancer	0.000167	0.000526	CcSEcCtD
Diltiazem—Nervousness—Doxorubicin—urinary bladder cancer	0.000167	0.000526	CcSEcCtD
Diltiazem—Vertigo—Epirubicin—urinary bladder cancer	0.000167	0.000526	CcSEcCtD
Diltiazem—Syncope—Epirubicin—urinary bladder cancer	0.000167	0.000525	CcSEcCtD
Diltiazem—Leukopenia—Epirubicin—urinary bladder cancer	0.000167	0.000524	CcSEcCtD
Diltiazem—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000166	0.000521	CcSEcCtD
Diltiazem—Palpitations—Epirubicin—urinary bladder cancer	0.000165	0.000518	CcSEcCtD
Diltiazem—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000164	0.000515	CcSEcCtD
Diltiazem—Cough—Epirubicin—urinary bladder cancer	0.000162	0.000511	CcSEcCtD
Diltiazem—Vision blurred—Doxorubicin—urinary bladder cancer	0.000162	0.000511	CcSEcCtD
Diltiazem—Infection—Methotrexate—urinary bladder cancer	0.000161	0.000507	CcSEcCtD
Diltiazem—Nausea—Etoposide—urinary bladder cancer	0.000161	0.000507	CcSEcCtD
Diltiazem—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.00016	0.000503	CcSEcCtD
Diltiazem—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000159	0.000501	CcSEcCtD
Diltiazem—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000159	0.0005	CcSEcCtD
Diltiazem—Chest pain—Epirubicin—urinary bladder cancer	0.000159	0.000499	CcSEcCtD
Diltiazem—Myalgia—Epirubicin—urinary bladder cancer	0.000159	0.000499	CcSEcCtD
Diltiazem—Arthralgia—Epirubicin—urinary bladder cancer	0.000159	0.000499	CcSEcCtD
Diltiazem—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000157	0.000494	CcSEcCtD
Diltiazem—Discomfort—Epirubicin—urinary bladder cancer	0.000157	0.000493	CcSEcCtD
Diltiazem—Malaise—Doxorubicin—urinary bladder cancer	0.000155	0.000489	CcSEcCtD
Diltiazem—Dry mouth—Epirubicin—urinary bladder cancer	0.000155	0.000488	CcSEcCtD
Diltiazem—Vertigo—Doxorubicin—urinary bladder cancer	0.000155	0.000487	CcSEcCtD
Diltiazem—Anorexia—Methotrexate—urinary bladder cancer	0.000155	0.000487	CcSEcCtD
Diltiazem—Syncope—Doxorubicin—urinary bladder cancer	0.000154	0.000486	CcSEcCtD
Diltiazem—Leukopenia—Doxorubicin—urinary bladder cancer	0.000154	0.000485	CcSEcCtD
Diltiazem—Palpitations—Doxorubicin—urinary bladder cancer	0.000152	0.000479	CcSEcCtD
Diltiazem—Oedema—Epirubicin—urinary bladder cancer	0.000152	0.000478	CcSEcCtD
Diltiazem—Hypotension—Methotrexate—urinary bladder cancer	0.000152	0.000477	CcSEcCtD
Diltiazem—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000151	0.000476	CcSEcCtD
Diltiazem—Infection—Epirubicin—urinary bladder cancer	0.000151	0.000475	CcSEcCtD
Diltiazem—Cough—Doxorubicin—urinary bladder cancer	0.00015	0.000473	CcSEcCtD
Diltiazem—Shock—Epirubicin—urinary bladder cancer	0.000149	0.00047	CcSEcCtD
Diltiazem—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000149	0.000469	CcSEcCtD
Diltiazem—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000149	0.000468	CcSEcCtD
Diltiazem—Tachycardia—Epirubicin—urinary bladder cancer	0.000148	0.000467	CcSEcCtD
Diltiazem—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000148	0.000465	CcSEcCtD
Diltiazem—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000147	0.000462	CcSEcCtD
Diltiazem—Insomnia—Methotrexate—urinary bladder cancer	0.000147	0.000462	CcSEcCtD
Diltiazem—Arthralgia—Doxorubicin—urinary bladder cancer	0.000147	0.000461	CcSEcCtD
Diltiazem—Chest pain—Doxorubicin—urinary bladder cancer	0.000147	0.000461	CcSEcCtD
Diltiazem—Myalgia—Doxorubicin—urinary bladder cancer	0.000147	0.000461	CcSEcCtD
Diltiazem—Paraesthesia—Methotrexate—urinary bladder cancer	0.000146	0.000459	CcSEcCtD
Diltiazem—Discomfort—Doxorubicin—urinary bladder cancer	0.000145	0.000456	CcSEcCtD
Diltiazem—Anorexia—Epirubicin—urinary bladder cancer	0.000145	0.000456	CcSEcCtD
Diltiazem—Dyspnoea—Methotrexate—urinary bladder cancer	0.000145	0.000455	CcSEcCtD
Diltiazem—Somnolence—Methotrexate—urinary bladder cancer	0.000144	0.000454	CcSEcCtD
Diltiazem—Dry mouth—Doxorubicin—urinary bladder cancer	0.000143	0.000451	CcSEcCtD
Diltiazem—Dyspepsia—Methotrexate—urinary bladder cancer	0.000143	0.00045	CcSEcCtD
Diltiazem—Hypotension—Epirubicin—urinary bladder cancer	0.000142	0.000447	CcSEcCtD
Diltiazem—Decreased appetite—Methotrexate—urinary bladder cancer	0.000141	0.000444	CcSEcCtD
Diltiazem—Oedema—Doxorubicin—urinary bladder cancer	0.000141	0.000442	CcSEcCtD
Diltiazem—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.00014	0.000441	CcSEcCtD
Diltiazem—Fatigue—Methotrexate—urinary bladder cancer	0.00014	0.00044	CcSEcCtD
Diltiazem—Infection—Doxorubicin—urinary bladder cancer	0.00014	0.000439	CcSEcCtD
Diltiazem—Pain—Methotrexate—urinary bladder cancer	0.000139	0.000437	CcSEcCtD
Diltiazem—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000138	0.000436	CcSEcCtD
Diltiazem—Shock—Doxorubicin—urinary bladder cancer	0.000138	0.000435	CcSEcCtD
Diltiazem—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000138	0.000434	CcSEcCtD
Diltiazem—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000138	0.000433	CcSEcCtD
Diltiazem—Insomnia—Epirubicin—urinary bladder cancer	0.000137	0.000432	CcSEcCtD
Diltiazem—Tachycardia—Doxorubicin—urinary bladder cancer	0.000137	0.000432	CcSEcCtD
Diltiazem—Paraesthesia—Epirubicin—urinary bladder cancer	0.000136	0.000429	CcSEcCtD
Diltiazem—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000136	0.000428	CcSEcCtD
Diltiazem—Dyspnoea—Epirubicin—urinary bladder cancer	0.000135	0.000426	CcSEcCtD
Diltiazem—Somnolence—Epirubicin—urinary bladder cancer	0.000135	0.000425	CcSEcCtD
Diltiazem—Anorexia—Doxorubicin—urinary bladder cancer	0.000134	0.000422	CcSEcCtD
Diltiazem—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000134	0.000421	CcSEcCtD
Diltiazem—Dyspepsia—Epirubicin—urinary bladder cancer	0.000134	0.000421	CcSEcCtD
Diltiazem—Decreased appetite—Epirubicin—urinary bladder cancer	0.000132	0.000416	CcSEcCtD
Diltiazem—Hypotension—Doxorubicin—urinary bladder cancer	0.000131	0.000413	CcSEcCtD
Diltiazem—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000131	0.000413	CcSEcCtD
Diltiazem—Fatigue—Epirubicin—urinary bladder cancer	0.000131	0.000412	CcSEcCtD
Diltiazem—Pain—Epirubicin—urinary bladder cancer	0.00013	0.000409	CcSEcCtD
Diltiazem—Constipation—Epirubicin—urinary bladder cancer	0.00013	0.000409	CcSEcCtD
Diltiazem—Urticaria—Methotrexate—urinary bladder cancer	0.000129	0.000406	CcSEcCtD
Diltiazem—Body temperature increased—Methotrexate—urinary bladder cancer	0.000128	0.000404	CcSEcCtD
Diltiazem—Abdominal pain—Methotrexate—urinary bladder cancer	0.000128	0.000404	CcSEcCtD
Diltiazem—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000128	0.000403	CcSEcCtD
Diltiazem—Insomnia—Doxorubicin—urinary bladder cancer	0.000127	0.0004	CcSEcCtD
Diltiazem—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000126	0.000397	CcSEcCtD
Diltiazem—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000125	0.000394	CcSEcCtD
Diltiazem—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000125	0.000394	CcSEcCtD
Diltiazem—Somnolence—Doxorubicin—urinary bladder cancer	0.000125	0.000393	CcSEcCtD
Diltiazem—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000124	0.000389	CcSEcCtD
Diltiazem—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000122	0.000384	CcSEcCtD
Diltiazem—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000121	0.000382	CcSEcCtD
Diltiazem—Fatigue—Doxorubicin—urinary bladder cancer	0.000121	0.000381	CcSEcCtD
Diltiazem—Urticaria—Epirubicin—urinary bladder cancer	0.000121	0.00038	CcSEcCtD
Diltiazem—Pain—Doxorubicin—urinary bladder cancer	0.00012	0.000378	CcSEcCtD
Diltiazem—Constipation—Doxorubicin—urinary bladder cancer	0.00012	0.000378	CcSEcCtD
Diltiazem—Body temperature increased—Epirubicin—urinary bladder cancer	0.00012	0.000378	CcSEcCtD
Diltiazem—Abdominal pain—Epirubicin—urinary bladder cancer	0.00012	0.000378	CcSEcCtD
Diltiazem—Hypersensitivity—Methotrexate—urinary bladder cancer	0.00012	0.000376	CcSEcCtD
Diltiazem—Asthenia—Methotrexate—urinary bladder cancer	0.000116	0.000366	CcSEcCtD
Diltiazem—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000116	0.000364	CcSEcCtD
Diltiazem—Pruritus—Methotrexate—urinary bladder cancer	0.000115	0.000361	CcSEcCtD
Diltiazem—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000112	0.000352	CcSEcCtD
Diltiazem—Urticaria—Doxorubicin—urinary bladder cancer	0.000112	0.000351	CcSEcCtD
Diltiazem—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000111	0.00035	CcSEcCtD
Diltiazem—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000111	0.00035	CcSEcCtD
Diltiazem—Diarrhoea—Methotrexate—urinary bladder cancer	0.000111	0.000349	CcSEcCtD
Diltiazem—Asthenia—Epirubicin—urinary bladder cancer	0.000109	0.000343	CcSEcCtD
Diltiazem—Pruritus—Epirubicin—urinary bladder cancer	0.000108	0.000338	CcSEcCtD
Diltiazem—Dizziness—Methotrexate—urinary bladder cancer	0.000107	0.000338	CcSEcCtD
Diltiazem—Diarrhoea—Epirubicin—urinary bladder cancer	0.000104	0.000327	CcSEcCtD
Diltiazem—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000104	0.000326	CcSEcCtD
Diltiazem—Vomiting—Methotrexate—urinary bladder cancer	0.000103	0.000325	CcSEcCtD
Diltiazem—Rash—Methotrexate—urinary bladder cancer	0.000102	0.000322	CcSEcCtD
Diltiazem—Dermatitis—Methotrexate—urinary bladder cancer	0.000102	0.000322	CcSEcCtD
Diltiazem—Headache—Methotrexate—urinary bladder cancer	0.000102	0.00032	CcSEcCtD
Diltiazem—Asthenia—Doxorubicin—urinary bladder cancer	0.000101	0.000317	CcSEcCtD
Diltiazem—Dizziness—Epirubicin—urinary bladder cancer	0.0001	0.000316	CcSEcCtD
Diltiazem—Pruritus—Doxorubicin—urinary bladder cancer	9.95e-05	0.000313	CcSEcCtD
Diltiazem—Vomiting—Epirubicin—urinary bladder cancer	9.66e-05	0.000304	CcSEcCtD
Diltiazem—Nausea—Methotrexate—urinary bladder cancer	9.64e-05	0.000303	CcSEcCtD
Diltiazem—Diarrhoea—Doxorubicin—urinary bladder cancer	9.62e-05	0.000303	CcSEcCtD
Diltiazem—Rash—Epirubicin—urinary bladder cancer	9.58e-05	0.000301	CcSEcCtD
Diltiazem—Dermatitis—Epirubicin—urinary bladder cancer	9.57e-05	0.000301	CcSEcCtD
Diltiazem—Headache—Epirubicin—urinary bladder cancer	9.52e-05	0.000299	CcSEcCtD
Diltiazem—Dizziness—Doxorubicin—urinary bladder cancer	9.3e-05	0.000292	CcSEcCtD
Diltiazem—Nausea—Epirubicin—urinary bladder cancer	9.03e-05	0.000284	CcSEcCtD
Diltiazem—Vomiting—Doxorubicin—urinary bladder cancer	8.94e-05	0.000281	CcSEcCtD
Diltiazem—Rash—Doxorubicin—urinary bladder cancer	8.86e-05	0.000279	CcSEcCtD
Diltiazem—Dermatitis—Doxorubicin—urinary bladder cancer	8.86e-05	0.000279	CcSEcCtD
Diltiazem—Headache—Doxorubicin—urinary bladder cancer	8.81e-05	0.000277	CcSEcCtD
Diltiazem—Nausea—Doxorubicin—urinary bladder cancer	8.35e-05	0.000263	CcSEcCtD
Diltiazem—CYP2C19—Metabolism—GSTO2—urinary bladder cancer	5.58e-05	0.000471	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—NAT1—urinary bladder cancer	5.58e-05	0.000471	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	5.49e-05	0.000463	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—MMP9—urinary bladder cancer	5.48e-05	0.000463	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—NAT2—urinary bladder cancer	5.47e-05	0.000462	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—PRSS3—urinary bladder cancer	5.47e-05	0.000462	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	5.45e-05	0.000461	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—GSTO2—urinary bladder cancer	5.44e-05	0.00046	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—NAT1—urinary bladder cancer	5.44e-05	0.00046	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—GSTZ1—urinary bladder cancer	5.41e-05	0.000457	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	5.39e-05	0.000455	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	5.36e-05	0.000453	CbGpPWpGaD
Diltiazem—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	5.31e-05	0.000448	CbGpPWpGaD
Diltiazem—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	5.23e-05	0.000442	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—EP300—urinary bladder cancer	5.2e-05	0.000439	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—CYP4B1—urinary bladder cancer	5.15e-05	0.000435	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	5.13e-05	0.000433	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—NAT1—urinary bladder cancer	5.13e-05	0.000433	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—UGT2B7—urinary bladder cancer	5.1e-05	0.000431	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—NAT1—urinary bladder cancer	5.09e-05	0.00043	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	5.09e-05	0.00043	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—SRC—urinary bladder cancer	5.06e-05	0.000427	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	5e-05	0.000422	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—HRAS—urinary bladder cancer	4.99e-05	0.000421	CbGpPWpGaD
Diltiazem—CACNA1C—Axon guidance—HRAS—urinary bladder cancer	4.99e-05	0.000421	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	4.98e-05	0.000421	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—SLC19A1—urinary bladder cancer	4.86e-05	0.00041	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—GSTP1—urinary bladder cancer	4.8e-05	0.000405	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—PRSS3—urinary bladder cancer	4.74e-05	0.0004	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—RRM2—urinary bladder cancer	4.72e-05	0.000399	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	4.69e-05	0.000396	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	4.65e-05	0.000393	CbGpPWpGaD
Diltiazem—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	4.63e-05	0.000391	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	4.59e-05	0.000388	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	4.57e-05	0.000386	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	4.48e-05	0.000379	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	4.47e-05	0.000377	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—TYMS—urinary bladder cancer	4.46e-05	0.000377	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—EGFR—urinary bladder cancer	4.43e-05	0.000374	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—NCOR1—urinary bladder cancer	4.41e-05	0.000373	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—GSTM1—urinary bladder cancer	4.41e-05	0.000373	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—ENO2—urinary bladder cancer	4.37e-05	0.000369	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—HPGDS—urinary bladder cancer	4.37e-05	0.000369	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—TYMP—urinary bladder cancer	4.37e-05	0.000369	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	4.34e-05	0.000366	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—GSTT1—urinary bladder cancer	4.24e-05	0.000358	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	4.23e-05	0.000358	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	4.23e-05	0.000357	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	4.22e-05	0.000357	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—GPX1—urinary bladder cancer	4.22e-05	0.000357	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—TNF—urinary bladder cancer	4.22e-05	0.000356	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	4.19e-05	0.000354	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—KRAS—urinary bladder cancer	4.19e-05	0.000354	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—ERCC2—urinary bladder cancer	4.15e-05	0.00035	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—PRSS3—urinary bladder cancer	4.13e-05	0.000348	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	4.04e-05	0.000341	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	3.99e-05	0.000337	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	3.95e-05	0.000334	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—NAT2—urinary bladder cancer	3.95e-05	0.000334	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	3.9e-05	0.00033	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—MTHFR—urinary bladder cancer	3.9e-05	0.000329	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	3.89e-05	0.000329	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	3.89e-05	0.000328	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	3.85e-05	0.000326	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.8e-05	0.000321	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—TYMP—urinary bladder cancer	3.79e-05	0.00032	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	3.71e-05	0.000314	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.64e-05	0.000307	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	3.61e-05	0.000305	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—HRAS—urinary bladder cancer	3.56e-05	0.000301	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	3.54e-05	0.000299	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—NQO1—urinary bladder cancer	3.52e-05	0.000298	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—NAT2—urinary bladder cancer	3.42e-05	0.000289	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—RRM2—urinary bladder cancer	3.41e-05	0.000288	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.39e-05	0.000286	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—TYMP—urinary bladder cancer	3.38e-05	0.000285	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	3.35e-05	0.000283	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—NAT1—urinary bladder cancer	3.35e-05	0.000283	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—TYMP—urinary bladder cancer	3.3e-05	0.000279	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.25e-05	0.000274	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	3.24e-05	0.000273	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	3.17e-05	0.000267	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—PPARG—urinary bladder cancer	3.16e-05	0.000267	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—ENO2—urinary bladder cancer	3.16e-05	0.000267	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	3.16e-05	0.000267	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—TYMP—urinary bladder cancer	3.11e-05	0.000262	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.09e-05	0.000261	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—TYMP—urinary bladder cancer	3.08e-05	0.00026	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	3.07e-05	0.000259	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	3.06e-05	0.000259	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—NAT2—urinary bladder cancer	3.06e-05	0.000258	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—CREBBP—urinary bladder cancer	3.04e-05	0.000256	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	3.01e-05	0.000255	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	2.99e-05	0.000253	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—NAT2—urinary bladder cancer	2.98e-05	0.000252	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.96e-05	0.00025	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—RRM2—urinary bladder cancer	2.96e-05	0.00025	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—GSTP1—urinary bladder cancer	2.94e-05	0.000248	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—NAT2—urinary bladder cancer	2.81e-05	0.000237	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—NAT2—urinary bladder cancer	2.79e-05	0.000235	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	2.76e-05	0.000233	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	2.74e-05	0.000231	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—ENO2—urinary bladder cancer	2.74e-05	0.000231	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—TYMS—urinary bladder cancer	2.73e-05	0.000231	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.72e-05	0.00023	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—NCOR1—urinary bladder cancer	2.7e-05	0.000228	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—GSTM1—urinary bladder cancer	2.7e-05	0.000228	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	2.66e-05	0.000224	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	2.65e-05	0.000224	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—RRM2—urinary bladder cancer	2.64e-05	0.000223	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.61e-05	0.000221	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	2.61e-05	0.00022	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—GPX1—urinary bladder cancer	2.59e-05	0.000218	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—RRM2—urinary bladder cancer	2.57e-05	0.000217	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—NQO1—urinary bladder cancer	2.55e-05	0.000215	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	2.54e-05	0.000215	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—ERCC2—urinary bladder cancer	2.54e-05	0.000214	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—PTGS2—urinary bladder cancer	2.49e-05	0.00021	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	2.44e-05	0.000206	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—ENO2—urinary bladder cancer	2.44e-05	0.000206	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.43e-05	0.000205	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—RRM2—urinary bladder cancer	2.43e-05	0.000205	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—RRM2—urinary bladder cancer	2.41e-05	0.000203	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	2.39e-05	0.000202	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—HPGDS—urinary bladder cancer	2.38e-05	0.000201	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—ENO2—urinary bladder cancer	2.38e-05	0.000201	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	2.37e-05	0.0002	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.33e-05	0.000197	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—GSTT1—urinary bladder cancer	2.31e-05	0.000195	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	2.25e-05	0.00019	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—ENO2—urinary bladder cancer	2.25e-05	0.00019	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	2.23e-05	0.000188	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—ENO2—urinary bladder cancer	2.23e-05	0.000188	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.21e-05	0.000187	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—NQO1—urinary bladder cancer	2.21e-05	0.000186	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	2.18e-05	0.000184	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—PTEN—urinary bladder cancer	2.17e-05	0.000183	CbGpPWpGaD
Diltiazem—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.17e-05	0.000183	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	2.16e-05	0.000182	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.14e-05	0.000181	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.13e-05	0.00018	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	2.12e-05	0.000179	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—EP300—urinary bladder cancer	2.07e-05	0.000175	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—TYMP—urinary bladder cancer	2.03e-05	0.000172	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—TYMS—urinary bladder cancer	1.98e-05	0.000167	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—NQO1—urinary bladder cancer	1.97e-05	0.000166	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	1.95e-05	0.000165	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	1.95e-05	0.000165	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—PPARG—urinary bladder cancer	1.94e-05	0.000163	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—NQO1—urinary bladder cancer	1.92e-05	0.000162	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.91e-05	0.000161	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—GPX1—urinary bladder cancer	1.87e-05	0.000158	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.87e-05	0.000158	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	1.86e-05	0.000157	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	1.84e-05	0.000155	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.84e-05	0.000155	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	1.84e-05	0.000155	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—NQO1—urinary bladder cancer	1.81e-05	0.000153	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—NQO1—urinary bladder cancer	1.8e-05	0.000152	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.78e-05	0.00015	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.74e-05	0.000147	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	1.73e-05	0.000146	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—TYMS—urinary bladder cancer	1.71e-05	0.000144	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	1.69e-05	0.000143	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	1.69e-05	0.000143	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.67e-05	0.000141	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	1.64e-05	0.000139	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—GPX1—urinary bladder cancer	1.62e-05	0.000137	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—GSTP1—urinary bladder cancer	1.6e-05	0.000135	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	1.59e-05	0.000134	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.59e-05	0.000134	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.59e-05	0.000134	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—TYMS—urinary bladder cancer	1.53e-05	0.000129	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	1.52e-05	0.000129	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.52e-05	0.000128	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	1.51e-05	0.000128	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	1.51e-05	0.000127	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	1.51e-05	0.000127	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	1.5e-05	0.000126	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	1.49e-05	0.000126	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—TYMS—urinary bladder cancer	1.49e-05	0.000126	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—NCOR1—urinary bladder cancer	1.47e-05	0.000124	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—GSTM1—urinary bladder cancer	1.47e-05	0.000124	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.47e-05	0.000124	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.47e-05	0.000124	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.45e-05	0.000122	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—GPX1—urinary bladder cancer	1.45e-05	0.000122	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.42e-05	0.00012	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	1.42e-05	0.00012	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—GPX1—urinary bladder cancer	1.41e-05	0.000119	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—TYMS—urinary bladder cancer	1.4e-05	0.000119	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—PPARG—urinary bladder cancer	1.4e-05	0.000118	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—TYMS—urinary bladder cancer	1.39e-05	0.000118	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	1.39e-05	0.000117	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	1.39e-05	0.000117	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—ERCC2—urinary bladder cancer	1.39e-05	0.000117	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	1.38e-05	0.000116	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	1.38e-05	0.000116	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	1.34e-05	0.000114	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	1.33e-05	0.000113	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—GPX1—urinary bladder cancer	1.33e-05	0.000112	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—PTEN—urinary bladder cancer	1.33e-05	0.000112	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—GPX1—urinary bladder cancer	1.32e-05	0.000111	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	1.31e-05	0.00011	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—MTHFR—urinary bladder cancer	1.3e-05	0.00011	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	1.29e-05	0.000109	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—EP300—urinary bladder cancer	1.27e-05	0.000107	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	1.23e-05	0.000104	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	1.22e-05	0.000103	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—PPARG—urinary bladder cancer	1.21e-05	0.000102	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.18e-05	0.0001	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	1.16e-05	9.83e-05	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	1.1e-05	9.3e-05	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—PPARG—urinary bladder cancer	1.08e-05	9.14e-05	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—PPARG—urinary bladder cancer	1.06e-05	8.92e-05	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	1.04e-05	8.78e-05	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—CREBBP—urinary bladder cancer	1.01e-05	8.57e-05	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—PPARG—urinary bladder cancer	9.95e-06	8.4e-05	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	9.88e-06	8.34e-05	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—PPARG—urinary bladder cancer	9.86e-06	8.33e-05	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—PTEN—urinary bladder cancer	9.6e-06	8.11e-05	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	9.56e-06	8.07e-05	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	9.53e-06	8.05e-05	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	9.47e-06	8e-05	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—TYMS—urinary bladder cancer	9.18e-06	7.76e-05	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—EP300—urinary bladder cancer	9.15e-06	7.73e-05	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	9.08e-06	7.67e-05	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	9.08e-06	7.67e-05	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—GPX1—urinary bladder cancer	8.69e-06	7.34e-05	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	8.53e-06	7.21e-05	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	8.51e-06	7.19e-05	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—PTEN—urinary bladder cancer	8.31e-06	7.02e-05	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—PTGS2—urinary bladder cancer	8.3e-06	7.01e-05	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	8.02e-06	6.77e-05	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—EP300—urinary bladder cancer	7.93e-06	6.7e-05	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	7.83e-06	6.61e-05	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	7.76e-06	6.55e-05	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—PTEN—urinary bladder cancer	7.42e-06	6.27e-05	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—PTEN—urinary bladder cancer	7.24e-06	6.12e-05	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—EP300—urinary bladder cancer	7.08e-06	5.98e-05	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—EP300—urinary bladder cancer	6.91e-06	5.83e-05	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—PTEN—urinary bladder cancer	6.83e-06	5.76e-05	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—PTEN—urinary bladder cancer	6.77e-06	5.71e-05	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—EP300—urinary bladder cancer	6.51e-06	5.5e-05	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—PPARG—urinary bladder cancer	6.5e-06	5.49e-05	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—EP300—urinary bladder cancer	6.45e-06	5.45e-05	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	6.25e-06	5.28e-05	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	5.12e-06	4.32e-05	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—PTEN—urinary bladder cancer	4.46e-06	3.77e-05	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—EP300—urinary bladder cancer	4.26e-06	3.59e-05	CbGpPWpGaD
